Rehabilitation medicine specialists from Columbia and Weill Cornell Medicine address complex challenges faced by patients with motor and functional deficits due to stroke, brain injury, and musculoskeletal trauma. Our physicians provide patients with services that range from exercise and medications to regenerative medicine treatments, and lead research into innovative therapies and devices to improve patient recovery.
Rehab Medicine
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
